Meet us at the 4th Global Bioequivalence Harmonization Initiative conference organised by AAPS and EUFEPS with active contribution of EMA and US-FDA. The conferences focuses on BE assessments for implants/long-acting injectables and for orally inhaled products as well as the necessity of fed BE studies in case of immediate release products